These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 27734563)

  • 1. Heart rate informed artificial pancreas system enhances glycemic control during exercise in adolescents with T1D.
    DeBoer MD; Cherñavvsky DR; Topchyan K; Kovatchev BP; Francis GL; Breton MD
    Pediatr Diabetes; 2017 Nov; 18(7):540-546. PubMed ID: 27734563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of an Artificial Pancreas System for Young Children with Type 1 Diabetes.
    DeBoer MD; Breton MD; Wakeman C; Schertz EM; Emory EG; Robic JL; Kollar LL; Kovatchev BP; Cherñavvsky DR
    Diabetes Technol Ther; 2017 May; 19(5):293-298. PubMed ID: 28426239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adding heart rate signal to a control-to-range artificial pancreas system improves the protection against hypoglycemia during exercise in type 1 diabetes.
    Breton MD; Brown SA; Karvetski CH; Kollar L; Topchyan KA; Anderson SM; Kovatchev BP
    Diabetes Technol Ther; 2014 Aug; 16(8):506-11. PubMed ID: 24702135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraperitoneal insulin delivery provides superior glycaemic regulation to subcutaneous insulin delivery in model predictive control-based fully-automated artificial pancreas in patients with type 1 diabetes: a pilot study.
    Dassau E; Renard E; Place J; Farret A; Pelletier MJ; Lee J; Huyett LM; Chakrabarty A; Doyle FJ; Zisser HC
    Diabetes Obes Metab; 2017 Dec; 19(12):1698-1705. PubMed ID: 28474383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outpatient Closed-Loop Control with Unannounced Moderate Exercise in Adolescents Using Zone Model Predictive Control.
    Huyett LM; Ly TT; Forlenza GP; Reuschel-DiVirgilio S; Messer LH; Wadwa RP; Gondhalekar R; Doyle FJ; Pinsker JE; Maahs DM; Buckingham BA; Dassau E
    Diabetes Technol Ther; 2017 Jun; 19(6):331-339. PubMed ID: 28459617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outpatient 60-hour day-and-night glucose control with dual-hormone artificial pancreas, single-hormone artificial pancreas, or sensor-augmented pump therapy in adults with type 1 diabetes: An open-label, randomised, crossover, controlled trial.
    Haidar A; Messier V; Legault L; Ladouceur M; Rabasa-Lhoret R
    Diabetes Obes Metab; 2017 May; 19(5):713-720. PubMed ID: 28094472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Closed loop control in adolescents and children during winter sports: Use of the Tandem Control-IQ AP system.
    Ekhlaspour L; Forlenza GP; Chernavvsky D; Maahs DM; Wadwa RP; Deboer MD; Messer LH; Town M; Pinnata J; Kruse G; Kovatchev BP; Buckingham BA; Breton MD
    Pediatr Diabetes; 2019 Sep; 20(6):759-768. PubMed ID: 31099946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Effects of Basal Insulin Suspension at the Start of Exercise on Blood Glucose Levels During Continuous Versus Circuit-Based Exercise in Individuals with Type 1 Diabetes on Continuous Subcutaneous Insulin Infusion.
    Zaharieva D; Yavelberg L; Jamnik V; Cinar A; Turksoy K; Riddell MC
    Diabetes Technol Ther; 2017 Jun; 19(6):370-378. PubMed ID: 28613947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of an artificial pancreas among adolescents for a missed snack bolus and an underestimated meal bolus.
    Cherñavvsky DR; DeBoer MD; Keith-Hynes P; Mize B; McElwee M; Demartini S; Dunsmore SF; Wakeman C; Kovatchev BP; Breton MD
    Pediatr Diabetes; 2016 Feb; 17(1):28-35. PubMed ID: 25348683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In Silico Analysis of an Exercise-Safe Artificial Pancreas With Multistage Model Predictive Control and Insulin Safety System.
    Garcia-Tirado J; Colmegna P; Corbett JP; Ozaslan B; Breton MD
    J Diabetes Sci Technol; 2019 Nov; 13(6):1054-1064. PubMed ID: 31679400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Closed-Loop Control of Postprandial Glycemia Using an Insulin-on-Board Limitation Through Continuous Action on Glucose Target.
    Rossetti P; Quirós C; Moscardó V; Comas A; Giménez M; Ampudia-Blasco FJ; León F; Montaser E; Conget I; Bondia J; Vehí J
    Diabetes Technol Ther; 2017 Jun; 19(6):355-362. PubMed ID: 28459603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Closed-Loop Control Without Meal Announcement in Type 1 Diabetes.
    Cameron FM; Ly TT; Buckingham BA; Maahs DM; Forlenza GP; Levy CJ; Lam D; Clinton P; Messer LH; Westfall E; Levister C; Xie YY; Baysal N; Howsmon D; Patek SD; Bequette BW
    Diabetes Technol Ther; 2017 Sep; 19(9):527-532. PubMed ID: 28767276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accuracy of Continuous Glucose Monitoring (CGM) during Continuous and High-Intensity Interval Exercise in Patients with Type 1 Diabetes Mellitus.
    Moser O; Mader JK; Tschakert G; Mueller A; Groeschl W; Pieber TR; Koehler G; Messerschmidt J; Hofmann P
    Nutrients; 2016 Aug; 8(8):. PubMed ID: 27517956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Closed-Loop Control During Intense Prolonged Outdoor Exercise in Adolescents With Type 1 Diabetes: The Artificial Pancreas Ski Study.
    Breton MD; Cherñavvsky DR; Forlenza GP; DeBoer MD; Robic J; Wadwa RP; Messer LH; Kovatchev BP; Maahs DM
    Diabetes Care; 2017 Dec; 40(12):1644-1650. PubMed ID: 28855239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adaptive Control of an Artificial Pancreas Using Model Identification, Adaptive Postprandial Insulin Delivery, and Heart Rate and Accelerometry as Control Inputs.
    Resalat N; Hilts W; Youssef JE; Tyler N; Castle JR; Jacobs PG
    J Diabetes Sci Technol; 2019 Nov; 13(6):1044-1053. PubMed ID: 31595784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of a Predictive Low-Glucose Management System In-Clinic.
    Buckingham BA; Bailey TS; Christiansen M; Garg S; Weinzimer S; Bode B; Anderson SM; Brazg R; Ly TT; Kaufman FR
    Diabetes Technol Ther; 2017 May; 19(5):288-292. PubMed ID: 28221823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Continuous Glucose Monitoring on Glycemic Control in Adolescents and Young Adults With Type 1 Diabetes: A Randomized Clinical Trial.
    Laffel LM; Kanapka LG; Beck RW; Bergamo K; Clements MA; Criego A; DeSalvo DJ; Goland R; Hood K; Liljenquist D; Messer LH; Monzavi R; Mouse TJ; Prahalad P; Sherr J; Simmons JH; Wadwa RP; Weinstock RS; Willi SM; Miller KM; ;
    JAMA; 2020 Jun; 323(23):2388-2396. PubMed ID: 32543683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do youth with type 1 diabetes exercise safely? A focus on patient practices and glycemic outcomes.
    Roberts AJ; Yi-Frazier JP; Aitken KE; Mitrovich CA; Pascual MF; Taplin CE
    Pediatr Diabetes; 2017 Aug; 18(5):367-375. PubMed ID: 27380934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dietary intake and risk of non-severe hypoglycemia in adolescents with type 1 diabetes.
    Zhong VW; Crandell JL; Shay CM; Gordon-Larsen P; Cole SR; Juhaeri J; Kahkoska AR; Maahs DM; Seid M; Forlenza GP; Mayer-Davis EJ
    J Diabetes Complications; 2017 Aug; 31(8):1340-1347. PubMed ID: 28476567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycemic Management Around Postprandial Exercise in People With Type 1 Diabetes: Challenge Accepted.
    Helleputte S; Stautemas J; Jansseune L; De Backer T; Marlier J; Lapauw B; Calders P
    J Clin Endocrinol Metab; 2024 Jul; 109(8):2039-2052. PubMed ID: 38330239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.